FDA proposes studies to examine influencer marketing impact on the audience

Tasim Zahid
January 31, 2020, 6:26 AM UTC

The regulatory body is currently accepting public comments on the proposed studies.

The Food and Drug Administration said it would examine the effectiveness of disclaimers on social ads for pharmaceuticals. The FDA and the Federal Trade Commission has been attempting to crack down on disclaimer-free online influencer marketing for some time now.

The agency has specifically proposed to conduct related two studies. While the first will focus on how consumers react to an endorsement by an influencer for an acne drug. The ad will either have no disclaimer or a direct statement like “paid ad.”

The other study would examine the response of roughly 700 web users on different disclaimer languages in a post. A Frankfurt-based law firm said that the new proposal could be a signal that the regulators are trying to build-up evidence to support the latest influencer marketing guidelines.'

Read the original article

[3 minute read]